Medicare Enrolled
Dr. Arash Rafiei Karkvand, MD
Urology Physician · Orange City, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rafiei Karkvand from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rafiei Karkvand?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rafiei Karkvand
Dr. Arash Rafiei Karkvand is an urology physician in Orange City, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Rafiei Karkvand performed 7,471 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rafiei Karkvand received a total of $10,756 from 63 pharmaceutical and/or device companies across 361 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rafiei Karkvand is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 16% volume in FL
$10,756 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗7,471
Medicare services
Top 16% in FL for urology physician
Not available
Unique patients (not deduplicated)
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,100 | $19 | $42 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,294 | $3 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,100 | $94 | $320 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
869 | $8 | $26 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
416 | $6 | $6 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
231 | $49 | $159 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
223 | $2 | $5 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
218 | $116 | $422 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
208 | $63 | $227 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
147 | $183 | $610 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 102 | $130 | $329 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
81 | $26 | $81 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
78 | $64 | $179 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
75 | $106 | $340 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
62 | $45 | $155 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
48 | $20 | $170 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
38 | $55 | $175 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
29 | $68 | $256 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
28 | $11 | $35 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
26 | $99 | $333 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
25 | $113 | $396 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
20 | $253 | $809 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
20 | $337 | $1,061 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
19 | $30 | $193 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
14 | $45 | $113 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.9% high complexity
42.9% medium
56.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,756
Total received (2018-2024)
Avg $1,537/year across 7 years
Top 19% in FL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
361
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,076
2023
$1,923
2022
$1,466
2021
$1,233
2020
$404
2019
$1,492
2018
$1,162
Payments by company (2024)
Medtronic, Inc.
$815
COLOPLAST CORP
$281
PROCEPT BioRobotics Corporation
$277
Dendreon Pharmaceuticals LLC
$272
Myriad Genetic Laboratories, Inc.
$179
PFIZER INC.
$169
Ferring Pharmaceuticals Inc.
$118
Janssen Biotech, Inc.
$97
Sumitomo Pharma America, Inc.
$84
Endo USA, Inc.
$70
SUN PHARMACEUTICAL INDUSTRIES INC.
$69
Endo Pharmaceuticals Inc.
$67
Astellas Pharma US Inc
$59
Rigicon,Inc.
$55
ABBVIE INC.
$52
Boston Scientific Corporation
$50
Novartis Pharmaceuticals Corporation
$49
Laborie Medical Technologies Corp.
$48
Janssen Scientific Affairs, LLC
$45
Merck Sharp & Dohme LLC
$39
ACCORD HEALTHCARE, INC.
$38
Tempus AI, Inc
$29
Kerecis Limited
$25
Verity Pharmaceuticals Inc.
$20
Blue Earth Diagnostics Limited
$20
Tolmar, Inc.
$19
Telix Pharmaceuticals
$19
UROGEN PHARMA, INC.
$14
Top 3 companies account for 44.7% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,325
Endo Pharmaceuticals Inc.
$1,037
Medtronic, Inc.
$815
COLOPLAST CORP
$676
Janssen Biotech, Inc.
$653
Rigicon,Inc.
$604
PFIZER INC.
$477
Dendreon Pharmaceuticals LLC
$452
Myriad Genetic Laboratories, Inc.
$401
Ferring Pharmaceuticals Inc.
$343
PROCEPT BioRobotics Corporation
$277
Merck Sharp & Dohme LLC
$255
Cook Medical LLC
$228
Teleflex LLC
$212
TOLMAR Pharmaceuticals, Inc.
$183
Sumitomo Pharma America, Inc.
$165
Coloplast Corp
$164
Johnson & Johnson Health Care Systems Inc.
$161
Janssen Scientific Affairs, LLC
$156
Boston Scientific Corporation
$155
Novartis Pharmaceuticals Corporation
$142
Baxter Healthcare
$123
Allergan, Inc.
$113
ABBVIE INC.
$111
UroGen Pharma, Inc.
$102
Allergan Inc.
$93
SUN PHARMACEUTICAL INDUSTRIES INC.
$88
Endo USA, Inc.
$70
ACCORD HEALTHCARE, INC.
$68
NeoTract Inc.
$58
Sun Pharmaceutical Industries Inc.
$56
Amgen Inc.
$55
Myovant Sciences Inc.
$53
Axonics, Inc.
$51
Antares Pharma, Inc.
$50
Laborie Medical Technologies Corp.
$48
Blue Earth Diagnostics Limited
$48
Bayer Healthcare Pharmaceuticals Inc.
$47
AstraZeneca Pharmaceuticals LP
$40
GENZYME CORPORATION
$36
KARL STORZ Endoscopy-America
$36
DENTSPLY IH Inc.
$35
Avadel Specialty Pharmaceuticals, LLC
$34
Tolmar, Inc.
$33
BOSTON SCIENTIFIC CORPORATION
$30
Omeros Corporation
$29
180 Medical, Inc.
$29
Tempus AI, Inc
$29
Retrophin, Inc.
$28
Alnylam Pharmaceuticals Inc.
$28
Foundation Medicine, Inc.
$26
MEDIVATION FIELD SOLUTIONS LLC
$25
Mission Pharmacal Company
$25
Kerecis Limited
$25
C. R. Bard, Inc. & Subsidiaries
$23
Verity Pharmaceuticals Inc.
$20
Telix Pharmaceuticals
$19
Olympus America Inc.
$18
Smith+Nephew, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$17
UROGEN PHARMA, INC.
$14
Profound Medical Corp.
$14
Ambu Inc.
$10
Top 3 companies account for 29.5% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · 27FR. ANGLED · ABIRATERONE ACETATE · ADSTILADRIN · AQUABEAM SYSTEM · AVEED · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · CCU · COOK MEDICAL ACCESSORIES · CUTTING LOOP · Cook Medical Holmium Laser Fiber · EDEX · ELIGARD · ERLEADA · Erleada · FIBER DUST · FIRMAGON · FLOSEAL · GENTLECATH GLIDE · GRAFIX PL · ILLUCCIX · IMAGE1 S X-LINK · INTERSTIM · JELMYTO · JEVTANA · KEYTRUDA · Kerecis Omega3 SurgiClose · LITHOCLAST · LITHOVUE · LUPRON DEPOT · LUTATHERA · LYNPARZA · LoFric · MODULAR · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · OXLUMO · Odomzo · Omidria · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · Prolaris · Prolia · REZUM · RIGI10 MALLEABLE PENILE PROSTHESIS · Rigi10 Malleable Penile Prosthesis · STERILE · SpaceOAR VUE System - 10mL · SpeediCath · TITAN · Titan · Trelstar · Tulsa-Pro · UROLIFT · US · Uribel · UroLift · UroLift System · Urocit-K · VESICARE · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
41
County median income
$66,581
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH FISH MEMORIAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rafiei Karkvand is a clinical cardiology specialist, with above-average Medicare volume (top 16% in FL), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rafiei Karkvand experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Rafiei Karkvand performed 2,100 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rafiei Karkvand receive payments from pharmaceutical companies?
Yes. Dr. Rafiei Karkvand received a total of $10,756 from 63 companies across 361 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rafiei Karkvand's costs compare to other urology physicians in Orange City?
Dr. Rafiei Karkvand's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rafiei Karkvand) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Orange City
Browse urology physicians in Orange City ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in FL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in FL
Which FL urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology